OTHER INFORMATION
−Removed: During the fiscal quarter ended June 30, 2023, none of the Company’s directors or officers (as defined in
−Removed: Rule 16a-1(f) of the Securities Exchange Act of 1934, as amended) adopted or terminated a Rule 10b5-1 trading arrangement or non-Rule
−Removed: 10b5-1 trading arrangement (as such terms are defined in Item 408 of Regulation S-K of the Securities Act of 1933, as amended).
+Added: the fiscal quarter ended September 30, 2023, none of the Company’s directors or officers (as defined in Rule 16a-1(f) of the Securities
+Added: Exchange Act of 1934, as amended) adopted or terminated a Rule 10b5-1 trading arrangement or non-Rule 10b5-1 trading arrangement (as
+Added: such terms are defined in Item 408 of Regulation S-K of the Securities Act of 1933, as amended).
+Added: Employment Agreement, dated September 5, 2023, between Elite Pharmaceuticals, Inc.
+Added: and Carter Ward (incorporated by reference to Exhibit 10.1 to the Current Report on Form 8-K filed with the SEC on September 7, 2023).
Certification of Chief Executive Officer pursuant to Exchange Act Rule 13a-14(a) and Rule 15d-14(a)*
+Added: Certification of Chief Financial Officer pursuant to Exchange Act Rule 13a-14(a) and Rule 15d-14(a)*
Certification of Chief Executive Officer pursuant to 18 U.S.C.
Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002**
−Removed: XBRL Instance Document
−Removed: XBRL Taxonomy Schema Document
−Removed: XBRL Taxonomy Extension Calculation Linkbase Document
−Removed: XBRL Taxonomy Extension Definition Linkbase Document
+Added: Certification of Chief Financial Officer pursuant to 18 U.S.C.
+Added: Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002**
+Added: Instance Document
+Added: Taxonomy Schema Document
+Added: Taxonomy Extension Calculation Linkbase Document
+Added: Taxonomy Extension Definition Linkbase Document
XBRL Taxonomy Extension Label Linkbase Document
−Removed: XBRL Taxonomy Extension Presentation Linkbase Document
+Added: Taxonomy Extension Presentation Linkbase Document
Page Interactive Data File (embedded within the Inline XBRL document)
+Added: Filed herewith.
+Added: Furnished herewith.
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by
1 unchanged sentence
PHARMACEUTICALS, INC.
−Removed: Executive Officer, President and
−Removed: of the Board of Directors
−Removed: Executive Officer, Principal Financial Officer, and Principal Accounting Officer)
+Added: Executive Officer, President and Chairman of the Board of Directors
+Added: Executive Officer)
+Added: Financial Officer
+Added: Accounting and Financial Officer)
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.